Certified by Founder Lodge
Panacea Venture
United States - Silicon Valley
INVESTOR
1 Disclosed Funding Rounds $59,500,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Panacea Venture is a life sciences venture capital firm with global vision and presence across three continents. The firm was founded in 2017 and is currently managing four funds investing in
| Company | Date | Round | Raised |
|---|---|---|---|
Actym Therapeutics, Inc. |
October, 20 ,2023 | Series A | $59,500,000 |
OutSee |
June, 25 ,2025 | Seed | $2,452,266 |
Actym Therapeutics, Inc.
OutSee
dezerv.
FalconX
Kristal.AI
Finary
Savart
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)